Delayed Hypersensitivity and Cell-Mediated Immunity: A Survey of Current Insights into These Responses of the Body to Antigens

Abstract

The field of delayed hypersensitivity continues to grow in complexity. One expects that increasing understanding of cell-mediated responses in clinical immunology will lead to greater advances in this field. This review explains and summarizes the pertinent newer concepts of clinical promise.

Get full access to this article

View all access options for this article.

References

Glick

, Chang

T. S.

and Jaap

R. G.

: The bursa of Fabricius and antibody production. Poultry Sci. 35: 224, 1956.

Glick

: Further evidence for the role of the bursa of Fabricius in antibody production. Poultry Sci. 37: 240, 1958.

Miller

J. F. A. P.

: Immunological function of the thymus. Lancet 2: 748, 1961.

Miller

J. F. A. P.

, Marshall

A. H. E.

and White

R. C.

: The immunological significance of the thymus. Adv. Immunol. 2: Ill, 1962.

Good

R. A.

, Dalmasso

A. P.

, Martinez

, Archer

O. K.

, Pierce

J. C.

and Papermaster

B. W.

: The role of the thymus in development of immunologic capacity in rabbits and mice. J. Exp. Med. 116: 773, 1962.

Martinez

, Kersey

, Papermaster

B. W.

and Good

R. A.

: Skin homograft survival in thymectomized mice. Proc. Soc. Exp. Biol. Med. 109: 193, 1962.

Cooper

M. D.

, Peterson

R. D. A.

and Good

R. A.

: Delineation of the thymic and bursal lymphoid systems in the chicken. Nature (London) 205: 143, 1965.

Waksman

B. H.

: Delayed hypersensitivity: immunologic and clinical aspects. In Immunobiology, Good

R. A.

and Fisher

D. W.

, Eds. Stanford, Conn, Sinauer Associates Inc., p. 28.

Bloom

B. R.

: In vitro approaches to the mechanism of cell-mediated immune reactions. Adv. Immunol. 13: 101, 1971.

10.

Good

R. A.

: Structure-function relations in the lymphoid system. In Clinical Immunobiology, Bach

F. H.

and Good

R. A.

, Eds. New York, Academic Press, 1972, Vol. 1, p. 1.

11.

Lawrence

H. S.

: Cellular immunity. In Clinical Immunobiology, Bach

F. H.

and Good

R. A.

, Eds. New York, Academic Press, 1972, Vol. 1, p. 47.

12.

David

J. R.

and David

R. R.

: Cellular hypersensitivity and immunity. Inhibition of macrophage migration and lymphocyte mediators. Progr. Allergy 16: 300, 1972.

13.

Warren

K. S.

: Pathophysiology and pathogenesis of hepatosplenic Schistosomiasis mansoni. Bull. N. Y. Acad. Med. 44: 280, 1968.

14.

Turk

J. L.

and Bryson

A. D. M.

: Immunological phenomena in leprosy and related diseases. Adv. Parasit. 13: 209, 1971.

15.

Patterson

P. Y.

: Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J. Exp. Med. 111: 119, 1960.

16.

Field

E. J.

and Caspary

E. A.

: Is maternal lymphocyte sensitization passed to the child. Lancet 2: 337, 1971.

17.

Henney

C. S.

and Waldman

R. H.

: Cell-mediated immunity shown by lymphocytes from the respiratory tract. Science 169: 696, 1970.

18.

Dumonde

D. C.

, Wolstencroft

R. A.

, Panayi

G. S.

, Matthew

, Morley

and Howson

W. T.

: “Lymphokines”: nonantibody mediators of cellular immunity generated by lymphocyte activation. Nature 224: 38, 1969.

19.

In vitro methods in cell-mediated immunity. Bloom

B. R.

and Glade

P. R.

, Eds. New York, Academic Press, 1971.

20.

Oppenheim

J. J.

: Relationship of in vitro lympho-cyte transformation to delayed hypersensitivity in guinea pigs and man. Fed. Proc. 27: 21, 1968.

21.

Oppenheim

J. J.

, Leventhal

B. G.

and Hersh

E. M.

: The transformation of column-purified lymphocytes with nonspecific and specific antigenic stimuli. J. Immunol. 101: 262, 1968.

22.

Bloom

B. R.

, Jimenz

and Marcus

P. I.

: A plaque assay for enumerating antigen-sensitive cells in delayed-type hypersensitivity. J. Exp. Med. 132: 16, 1970.

23.

Wybran

, Levin

A. S.

, Spitler

L. E.

and Fundenberg

H. H.

: Rosette-forming cells, immunologic deficiency diseases and transfer factor. N. Engl. J. Med. 288: 710, 1973.

24.

Bloom

B. R.

and Bennett

: Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153: 80, 1966.

25.

David

J. R.

: Delayed hypersensitivity in vitro. Its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Nat. Acad. Sci. Wash. 56: 72, 1966.

26.

Rocklin

R. E.

, Meyers

O. C.

and David

J. R.

: An in vitro assay for cellular hypersensitivity in man. J. Immunol. 104: 95, 1970.

27.

Søborg

and Bendixen

: Human lymphocyte migration as a parameter of hypersensitivity. Acta Med. Scand. 181: 247, 1967.

28.

Lolekha

, Dray

and Gotoff

S. P.

: Macrophage aggregation in vitro. A correlate of delayed hypersensitivity. J. Immunol. 104: 296, 1970.

29.

Ward

P. A.

, Remold

H. G.

and David

J. R.

: Leukotactic factor produced by sensitized lymphocytes. Science 163: 1079, 1969.

30.

Ward

P. A.

, Remold

H. G.

and David

J. R.

: The production by antigen-stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factor. Cellular Immunol. 1: 162, 1970.

31.

Mackaness

G. B.

: The immunological basis of acquired cellular resistance. J. Exp. Med. 120: 105, 1964.

32.

Mackaness

G. B.

: The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J. Exp. Med. 129: 973, 1969.

33.

Mackaness

G. B.

: The monocyte in cellular immunity. Seminars in Hematology 7: 172, 1970.

34.

Bloom

B. R.

and Bennett

: Macrophages and delayed-type hypersensitivity. Seminars in Hematology 7: 215, 1970.

35.

Van Furth

, Cohn

Z. A.

, Hirsch

J. G.

, Humphrey

J. A.

, Spector

W. G.

and Langevoort

H. L.

: The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. Bull. WHO 46: 845, 1972.

36.

Snyderman

, Altman

L. C.

, Frankel

and Blaese

R. M.

: Defective mononuclear leukocyte chemotaxis: a previously unrecognized immune dysfunction. Ann. Intern. Med. 78: 509, 1973.

37.

Rosenau

S. A.

and Moon

H. D.

: Lysis of homologous cells by sensitized lymphocytes in tissue culture. J. Nat. Cancer Inst. 27: 471, 1961.

38.

Granger

G. A.

and Williams

T. W.

: Lymphocyte cytotoxicity in vitro. Activation and release of a cytotoxic factor. Nature (London) 218: 1253, 1968.

39.

Ruddle

N. H.

and Waksman

B. H.

: Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. II. Correlation of the in vitro response with skin reactivity. J. Exp. Med. 128: 1255, 1968.

40.

Green

J. A.

, Cooperband

S. R.

, Rutstein

J. A.

and Kibrick

: Inhibition of target cell proliferation by supernatants from cultures of human peripheral lymphocytes. J. Immunol. 105: 48, 1970.

41.

Landsteiner

and Chase

M. W.

: Experiments on transfer of cutaneous sensitivity to simple compounds. Proc. Soc. Exp. Biol. Med. 49: 688, 1972.

42.

Chase

M. W.

: The cellular transfer of cutaneous hypersensitivity to tuberculin. Proc. Soc. Exp. Med. 59: 134, 1945.

43.

Thor

D. E.

: Delayed hypersensitivity in man. An in vitro correlate and transfer by an RNA extract. Science 157: 1567, 1967.

44.

Baram

and Mosko

M. M.

: A dialyzable fraction from tuberculin-sensitive human white blood cells capable of inducing tuberculin-delayed hypersensitivity in negative recipients. Immunology 8: 461, 1965.

45.

Maddison

S. E.

, Hicklin

M. D.

, Conway

B. P.

and Kagan

I. G.

: Transfer factor: delayed hypersensitivity to Schistosoma mansoni and tuberculin in Macaca, mulatta. Science 178: 757, 1972.

46.

Lawrence

H. S.

, Al-Askari

, David

J. R.

, Franklin

E. C.

and Zweiman

: Transfer of immunological information in humans with dialysates of leukocyte extracts. Trans. Amer. Ass. Phys. 76: 84, 1963.

47.

Lawrence

H. S.

: Transfer factor. Adv. Immunol. 11: 195, 1969.

48.

Schulkind

M. L.

, Adler

W. H.

, Altermeier

W. A.

III and Ayouba

E. M.

: Transfer factor in the treatment of a case of chronic mucocutaneous candidiasis. Cell. Immunol. 3: 606, 1972.

49.

Pabst

H. F.

and Swanson

: Successful treatment of candidiasis with transfer factor. Br. Med. J. 2: 442, 1972.

50.

Kirkpatrick

C.H.

, Rich

R. R.

and Smith

T. K.

: Effect of transfer factor on lymphocyte function in anergic patients. J. Clin. Invest. 51: 2948, 1972.

51.

Levin

A. S.

, Spitler

L. E.

, Stites

D. P.

and Fudenberg

H. H.

: Wiskott-Aldrich syndrome, a genetically determined cellular immunologic deficiency: clinical and laboratory responses to therapy with transfer factor. Proc. Natl. Acad. Sci. USA 67: 821, 1970.

52.

Bullock

W. E.

, Fields

J. P.

and Brandiss

M. W.

: An evaluation of transfer factor as immunotherapy for patients with lepromatous leprosy. N. Engl. J. Med. 287: 1053, 1972.

53.

Lawrence

H. S.

: Immunotherapy with transfer factor. N. Engl. J. Med. 287: 1092, 1972.

54.

Brandes

L. J.

, Salton

D. A. G.

and Wiltshaw

: New approach to immunotherapy of melanoma. Lancet 2: 293, 1971.

55.

Spitler

L. E.

, Levin

A. S.

, Blois

M. S.

, Epstein

, Fudenberg

H. H.

, Hellstrom

and Hellstrom

K. E.

: Lymphocyte responses to tumor-specific antigens in patients with malignant melanoma and results of transfer factor therapy. J. Clin. Invest. 51: 92 (Abstract), 1972.